Covid vaccine: The US Plans To Set The Booster Dose Different From The Initial
The United States Food and Drug Administration (FDA ) is planning to allow citizens to receive a vaccine (as a booster dose) against the Covid-19 coronavirus from a different laboratory than the one they received in the first and second, reports The New York Times.
In September, the FDA authorized a booster dose of Pfizer’s Covid-19 vaccine in people 65 and older and citizens at high risk for their vulnerability. It has also endorsed the use of Moderna and Janssen booster vaccines.
The United States Government does not recommend one vaccine over another and indicates thatit is preferable to give the same vaccine as a booster when possible.
Is it recommended to mix Covid vaccines?
On October 15, when a group of advisers from federal regulators approved the boosters of the single-dose vaccine for Johnson & Johnson (Janssen), the committee’s scientists debated a question that many people ask: is it a good idea to mix and match vaccines?
The question arose after the panel heard a presentation on a study showing that the combined inoculation approach gives patients who received the vaccine a stronger antibody response.